Company Overview and News

2
Market report: Anglo climbs on talk of Vedanta tie-up

2018-07-04 telegraph.co.uk
Mining giant Anglo American leapt ahead of its sinking rivals on reports that its top shareholder, Indian metals tycoon Anil Agarwal, is plotting an ambitious move to merge his Vedanta Resources and the FTSE 100 firm’s South African assets.
RIO BLT RIO BHPBF AAL RTPPF VED BHP AAUKF RIO RTNTF BBL BHP BHPLF NGLOY

2
Vedanta weighs $7 billion merger with Anglo American South Africa

2018-07-04 livemint
Mumbai: Volcan Investments Ltd, the family trust of Vedanta Resources Plc. founder Anil Agarwal, is considering a plan to acquire control of Anglo American Plc’s South African business by merging Vedanta Resources with the South African unit via a share swap, two people directly aware of the plan said.
AGPPF RIO BLT RIO VALE3 BHPBF AAL ANGPY KIROY AGPPY RTPPF VED KUMBF BHP AAUKF RIO RTNTF BBL LNSTY BHP BHPLF NGLOY

2
Cheering Vedanta Ltd’s elevation as listed flagship may be premature

2018-07-03 livemint
Vedanta Resources Plc’s decision to delist from exchanges appears to have pleased Vedanta Ltd’s (Vedanta) investors. If Vedanta becomes the vehicle for the group’s future global investments, they will get a slice of that action as well. But that’s a long shot.
VED AAUKF AAL NGLOY VEDL

4
Anil Agarwal’s family trust to buy rest of Vedanta Resources

2018-07-02 livemint
Bengaluru: Vedanta Resources Plc said on Monday that chairman Anil Agarwal’s family trust has agreed to buy the rest of the company in a deal that values the mining conglomerate at £2.3 billion ($3.03 billion). An independent committee, formed to review and evaluate the proposal, has indicated to Volcan Investments that it supports the offer and intends to recommend a firm offer to Vedanta’s shareholders.
VED AAUKF AAL NGLOY

4
Vedanta up 2% as Anil Agarwal likely to buy remaining stake in company

2018-07-02 moneycontrol
Shares of Vedanta advanced 2.5 percent intraday Monday as company's chairman Anil Agarwal is likely to buy remaining stake in the company.
VED AAUKF AAL NGLOY

5
Centaurus Metals intersects strong nickel-cobalt grades at Brazilian project

2018-07-02 proactiveinvestors.com.au
Centaurus Metals Ltd (ASX:CTM) has highlighted the growing scale and potential of its Brazilian nickel-cobalt project with further strong intersections from ongoing drilling at Itapitanga.
VALE3 AAUKF CTM AAL NGLOY

22
FOCUS-Rio Tinto ready to splash out on copper

2018-06-29 reuters
The global miner would be willing to fork out a large premium over market value to secure a prime asset as it tries to reduce its reliance on iron ore, company and banking sources told Reuters.
RIO RIO LUNMF CPNFD AAL LUNCF LUN RTPPF AAUKF RIO RTNTF FQVLF FQM NGLOY

22
FOCUS-Rio Tinto ready to splash out on copper

2018-06-29 reuters
LONDON, June 29 (Reuters) - Rio Tinto wants copper badly, and it’s ready to pay top-dollar.
RIO RIO LUNMF CPNFD AAL LUNCF LUN RTPPF AAUKF RIO RTNTF FQVLF FQM NGLOY

4
Bahrain Steel says Anglo declared force majeure on contract after spills

2018-06-28 channelnewsasia
RIO DE JANEIRO/DUBAI: Anglo American has suspended a contract to supply Bahrain Steel with iron ore, the Gulf-based company said, in the latest headache for the miner's troubled Brazilian project after spills from a pipeline that carries the commodity to port.
PRMLY LLXLF AAUKF AAL NGLOY

4
Exclusive: Bahrain Steel says Anglo declared force majeure on contract after spills

2018-06-27 channelnewsasia
Anglo American has suspended a contract to supply Bahrain Steel with iron ore, the Gulf-based company said, in the latest headache for the miner's troubled Brazilian project after spills from a pipeline that carries the commodity to port.
PRMLY LLXLF AAUKF AAL NGLOY

4
Exclusive: Bahrain Steel says Anglo declared force majeure on contract after spills

2018-06-27 reuters
RIO DE JANEIRO/DUBAI (Reuters) - Anglo American (AAL.L) has suspended a contract to supply Bahrain Steel with iron ore, the Gulf-based company said, in the latest headache for the miner’s troubled Brazilian project after spills from a pipeline that carries the commodity to port.
PRMLY LLXLF AAUKF AAL NGLOY

4
Glencore Bets Big on South Africa as Ramaphosa Promises Revival - Bloomberg

2018-06-26 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
AAUKF CVX AAL NGLOY

7
Japan's Sumitomo says to buy 5-pct stake in Peruvian gold mine

2018-06-21 reuters
TOKYO, June 21 (Reuters) - Japanese trading house Sumitomo Corp on Thursday said it had agreed to buy a 5-percent stake in the Yanacocha gold mine in Peru for $48 million, as it looks to boost its assets in the metals sector.
NEM AAUKF SSUMF AAL NGLOY

18
Gold Street Is Where South Africa’s Mining History Goes to Die - Bloomberg

2018-06-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
HMY AGPPF TM TYT AU AAL JMPLF TOYOF IMPUY ANGPY AULGF AGPPY AAUKF 7203 JMPLY IMPUF AGG NGLOY HGMCF

7
Anglo American, Milliken & Company, MOL Group, Koch Industries, Goldcorp and AccorHotels among the Excellence Award winners at Enablon’s Sustainable Performance Forum

2018-06-20 globenewswire
CHICAGO, June 20, 2018 (GLOBE NEWSWIRE) -- Enablon, a Wolters Kluwer business and the world’s leading provider of EHS, Operational Risk Management and Sustainability Software, announced today the winners of the 2018 Enablon Excellence Awards. The awards were given during a gala dinner at the Sustainable Performance Forum (SPF) in Chicago, and in Paris.
AAUKF AAL WKL NGLOY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 03485P201